BIOTRICITY INC. (OTCMKTS:BTCY) Files An 8-K Regulation FD Disclosure

0

BIOTRICITY INC. (OTCMKTS:BTCY) Files An 8-K Regulation FD Disclosure

Item 7.01

Regulation FD Disclosure

On April 12, 2017, Biotricity, Inc., a Nevada corporation (the
Registrant), announced that it has filed for a second and final
510(k) for the hardware portion of its Bioflux solution with
the U.S. Food and Drug Administration.

A copy of the press release is furnished as Exhibit 99.1 to
this Current Report on Form 8-K and is incorporated herein by
reference. The information in this report (including Exhibit
99.1) is being furnished to Item 7.01 and shall not be deemed
to be filed for the purposes of Section 18 of the Securities
Exchange Act of 1934, as amended, or otherwise subject to the
liabilities of that section. This report will not be deemed an
admission as to the materiality of any information herein
(including Exhibit 99.1).

Item 9.01

Financial Statements and Exhibits

(d)

Exhibits. The exhibit listed in the following Exhibit
Index are furnished as part of this Current Report on Form 8-K:

Exhibit No.

Description

99.1

Press Release


About BIOTRICITY INC. (OTCMKTS:BTCY)

Biotricity Inc is a Canada-based medical technology company. The Company delivers remote biometric monitoring solutions, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. It offers bioflux, an Electrocardiogram (ECG) monitoring system that enables physicians to diagnose cardiovascular diseases or coronary heart diseases, acts as an ambulatory monitor that detects arrhythmias, performs remote mobile cardiac telemetry diagnostic monitoring, and transmits ECG data via a built-in cellular radio in real time. The Company also provides biolife, a health and lifestyle solution for individuals, which consists of a device that monitors heart-rhythm or ECG, as well as respiration, calories, temperature, physical activity, and other.

BIOTRICITY INC. (OTCMKTS:BTCY) Recent Trading Information

BIOTRICITY INC. (OTCMKTS:BTCY) closed its last trading session up +0.10 at 2.50 with 560 shares trading hands.